Skip to main content
Recall Canary
Levothyroxine Sodium Tablets USP 150 mcg
← Back to all recalls
DRUG RECALLMODERATE

Levothyroxine Sodium Tablets USP 150 mcg

Macleods Pharma recalls Levothyroxine Sodium 150 mcg tablets (NDC 33342-401-44) nationwide due to subpotency.

What to do

Do not use this medication. Contact your pharmacy or healthcare provider immediately to obtain a replacement supply from an unaffected lot. Do not stop taking levothyroxine without medical guidance.

Posted
Updated
Recall No.
D-0403-2026
Agency
Firm
MACLEODS PHARMA USA, INC
Recall ID
98510
Status
ONGOING

Why it was recalled

Subpotent Drug

How to identify it

Levothyroxine Sodium Tablets USP 150 mcg, 1000 Tablets bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Princeton, NJ, Manufactured by: Macleods Pharmaceuticals Ltd., Sarigam, Valsad, Guajarat, INDIA NDC 33342-401-44

Where it was sold

Distributed in US.

← Back to all recalls

Editorial summary by Recall Canary · last updated 2026-04-27 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification